COPD trials in Singapore

2 of 3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  Where

  Singapore

  Age

  40 years to 80 years

  People

  942 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07190222 · EU 2024-518213-25-00
• Phase 4Taking people
  A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

  Where

  Singapore

  Age

  40 years to 85 years

  People

  218 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07053423